Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
BMC
2023-05-01
|
| Seri Bilgileri: | Journal of Translational Medicine |
| Online Erişim: | https://doi.org/10.1186/s12967-023-04186-4 |